The Hill Prizes

Hill Prizes Website Header

2027 Hill Prizes Information Sessions

Join TAMEST for information sessions on the 2027 Hill Prizes on Wednesday, April 15, 2026, and learn more about the upcoming application cycle. Two sessions will be offered via Zoom:

Academic Session – 10:00-10:45 a.m. CT: Covers the Hill Prizes in Artificial Intelligence, Biological Sciences, Engineering, Medicine, Physical Sciences and Public Health | Register Here >

Private Sector Session – 1:00-1:45 p.m. CT: Covers the Hill Prize in Commercialization, Innovation and Technology (exclusively for the private sector) and Hill Prize in Artificial Intelligence (open to both academia and the private sector). Lynda Chin, M.D. (NAM), Hill Prize in Commercialization, Innovation and Technology Subcommittee Chair, will help lead the session. | Register Here >

During the sessions, Hill Prizes Committee Chair David E. Daniel, Ph.D. (NAE), will review the purpose of the prizes, the application process and key evaluation criteria, followed by Q&A.

Academic Information Session

Wednesday, April 15, 2026
10:00-10:45 a.m. CT

Private Sector Information Session

Wednesday, April 15, 2026
1:00-1:45 p.m. CT

2027 Hill Prizes Call for Applications

Applications for the 2027 Hill Prizes will open May 1, 2026 and close June 1, 2026, 6:00 p.m. CT.

Learn more about the prizes and selection process below. For questions, please contact TAMEST Program Director Stephanie Shaw at (512) 471-3823 or stephanie.shaw@austin.utexas.edu.

The Hill Prizes, funded by Lyda Hill Philanthropies, recognize and advance top Texas innovators whose high-risk, high‑reward ideas have potential for significant real‑world impact. The prizes aim to elevate exceptional researchers, accelerate paradigm‑shifting science and position Texas as a premier destination for world‑class innovation. By providing funding that helps bridge the gap between early‑stage research and business development, the Hill Prizes strengthen recipients’ ability to pursue large‑scale grants, build collaborations and bring transformative discoveries closer to practical application.

The Hill Prizes have seven categories: artificial intelligence; commercialization, innovation and technology; biological sciences; engineering; medicine; physical sciences; and public health. The Hill Prize in Artificial Intelligence (AI) will be given to researchers and teams at academic and medical institutions and in government and in the private sector (including university and government spinout companies). The biological sciences, engineering, medicine, physical sciences and public health prizes will be given to researchers and teams at academic and medical institutions. The Hill Prize in Commercialization, Innovation and Technology will be given to individuals and teams in the private sector in applied sciences, biotechnology, engineering, life sciences and medicine.

Lyda Hill Philanthropies has committed over $10 million in funding to continue the prize program and include at least $1 million in discretionary research funding allocated by Lyda Hill Philanthropies on an ad hoc basis to highly ranked applicants and finalists not selected as recipients.

Each prize recipient’s institution or organization will receive $500,000 in direct, non-dilutive funding from Lyda Hill Philanthropies to accelerate their work. Prize recipients will be announced in January 2027 and recognized on February 1, 2027, at the opening reception of the TAMEST 2027 Annual Conference in Houston, Texas.

The goal of the prizes is to recognize exceptional innovators and provide seed funding to advance innovative science and highlight Texas as a premier destination for world-class research. The prizes will bridge the path from research to business development and further innovations that need additional funding to have a greater impact. The Hill Prizes will also put recipients in a stronger position to receive more research funding and seek large-scale grants and collaborations.

Hill Prizes Overview

Click on a category below to learn more about the Hill Prizes.

Who May Apply?

Eligibility Requirements

Open to all Texas‑based applicants (including TAMEST members), 15 years or more after their first full-time appointment (2011or earlier).

  • Artificial Intelligence: Open to applications from academia, government, medicine and the private sector (including university and government spinout companies).
  • Biological Sciences, Engineering, Medicine, Physical Sciences and Public Health: Open to applications from all research universities, medical centers, nonprofit research institutes and other scientific organizations in Texas.
  • Commercialization, Innovation and Technology (exclusive to private sector): Open to applications from all companies, private research institutes and other scientific and research organizations in the private sector in Texas (including university and government spinout companies).

Applicants must have spent the past two years (at time of submission) performing research in Texas and remain active in the state for at least one year after receiving the prize funding.

Application Categories

Applicants may submit only one proposal per category, and may not submit the same proposal in more than one category. The committee reserves the right to reassign a proposal to a different category if deemed appropriate.

Subcategories may include, but are not limited to, the following:

Artificial Intelligence: Designated for proposals that make substantive, novel, impactful advancement in AI capabilities to address an important challenge. Topics may include:

  • Advanced Platform Development for AI
  • AI Hardware/Infrastructure Development
  • Innovative Training Methods
  • Pioneering Applications of AI
  • Theoretical Developments and Algorithms (including significant advances in Generative AI, Agentic AI, Artificial General Intelligence, Machine Learning and Optimization)

Biological Sciences:

  • Animal Biology
  • Ecology and Environmental Science
  • Entomology
  • Infectious Diseases and Immunology
  • Microbiology
  • Plant Biology

Commercialization, Innovation and Technology: Designated for proposals in the private sector in applied sciences, biotechnology, engineering, life sciences and medicine. For information, please refer to the separate application guide.

Engineering:

  • Aerospace Engineering
  • Biomedical Engineering
  • Chemical Engineering
  • Civil, Architectural and Environmental Engineering
  • Electrical and Computer Engineering
  • Electronics, Communications, Information Systems and Control Systems
  • Industrial and Manufacturing Engineering
  • Materials Engineering
  • Mechanical Engineering

Medicine:

  • Autoimmune Disorders
  • Cardiopulmonary Diseases
  • Clinical Pharmacology
  • Gastrointestinal Diseases
  • Maternal and Children’s Health
  • Musculoskeletal Disorders
  • Neuropsychiatric Disorders
  • Oncology
  • Pathology
  • Psychiatry

Physical Sciences:

  • Astronomy
  • Chemistry
  • Computer Science
  • Earth Sciences
  • Mathematics
  • Physics
  • Solar and Space Physics

Public Health: Designated for proposals focused on protecting the health of entire populations through science, technology and policy:

  • Behavioral Health
  • Biostatistics
  • Clinical Cancer Prevention
  • Community Health
  • Disease Control and Prevention
  • Epidemiology
  • Environmental and Occupational Health
  • Health Disparities
  • Health Policy and Management
  • Health Promotion and Education
  • Mental Health
  • Nutrition and Food Safety
  • Psychology
Selection Criteria and Process

A committee of Texas-based members of the National Academies evaluates applications and recommends recipients, in consultation with a panel of National Academies members from outside of Texas. A committee of Texas Nobel and Breakthrough Prize Laureates reviews and endorses the finalists, and the TAMEST Board of Directors provides final approval. Prizes are only given when the committee identifies and selects deserving proposals.

Submissions will be judged on the following criteria:

  • Uniqueness of idea behind the research;
  • Potential for commercial application and/or real-world impact;
  • Strengths of research group leader and/or team;
  • Ability and availability of key personnel and infrastructure to execute the work and achieve success with the prize funding to be awarded.
    Required Application Materials

    Apply Online: tamest.org/submit

    The following components are required to be submitted as one .pdf document through the online application form. Proposals should be formatted in Times New Roman 11-point font with margins of at least 0.5”. Letters of recommendation or support are not permitted and will not be accepted. Key citations (not to exceed one page) may be included at the end of the single‑PDF proposal.

    1.) Cover page (not to exceed one page and must use template), including:

    • Selected prize category, and a brief statement on why the proposal fits the selected category;
    • Proposal title;
    • Summary statement (≤50 words) describing:
      • Summary of the project and why it should be chosen for the Hill Prizes;
      • Potential impact of the project.
    • Abstract (≤ 250 words) of proposal addressing the following:
      • What problem are you trying to solve, and how is it addressed today (if at all)?
      • What is novel about your approach?
      • If successful, what will be the impact?
        • For the Artificial Intelligence (AI) Category: What is your substantive, novel advancement(s) in the development of technologies that support AI and/or AI capabilities to address an important challenge?
    • Applicant information:
      • Principal Investigator’s name, title and organization;
      • Principal Investigator’s address, email and telephone contact information;
      • Principal Investigator’s year of first full-time appointment (must be 2011 or earlier);
      • Names of Co-Recipient(s) and team members.

    2.) Project proposal (up to five pages) defining:

    • The problem being addressed, the key gap the proposed work will fill and the
      limitations of current approaches that make the applicant’s solution necessary
      and distinctively novel;
    • The potential impact of the work, supported by relevant metrics when
      available, including any potential commercial or translational applications and
      the overall path to impact;
    • How the recipient would use the Hill Prizes funding to accelerate their work
      and make a significant impact on society.
      • Applicants should clearly disclose any existing or potential funding for their
        proposal – or any closely related idea – and explain how the Hill Prizes
        funding would be used to bridge a gap or enable meaningful advances for
        their idea in addition to their existing or potential funding.
      • Detailed budgets are not required. However, applicants should list how
        funding would be used (e.g., for equipment, personnel or other major
        expenses), including approximate amounts for each major category.

    3.) Biographical summary for the Principal Investigator (NIH/NSF Biosketch accepted, up to three pages), including:

    • Education, employment history, honors, recognitions and awards;
    • Summary of research interests and activities, including (as applicable) significant grant support or major projects and the PI’s role;
    • Citations for up to 10 key publications;
    • Synopsis of major discoveries and research contributions;
    • Summary statistics on publications, books, patents (if applicable) and reports.

    For team members, a brief biographical summary (up to one page) may be included for each team member.

    Deadline for Submission of Application Materials
    Applications for the 2027 Hill Prizes will open May 1, 2026, and close June 1, 2026, 6 p.m. CT.
    Prize Funding and Recipient Requirements

    Funding

    • Each recipient’s institution or organization will receive $500,000 in direct, non- dilutive funding from Lyda Hill Philanthropies. Funds must adhere to the institution’s spending policies and may not be used for institutional overhead or indirect costs. Funds are expected to be expended in a timely manner to advance the proposed work.
    • Proposals should span at least one year with an expected start date in March 2027.
    • Applicants retain all intellectual property rights associated with their work.

    Ceremony

    • Principal Investigators are required to attend the prize ceremony on February 1, 2027, at the TAMEST Annual Conference in Houston, Texas. Travel and lodging will be provided for Principal Investigators to attend.

    Reporting

    • Recipients must submit reporting to Lyda Hill Philanthropies annually per the terms of the grant agreement.
    • TAMEST and Lyda Hill Philanthropies may publicly share information contained in these reports to demonstrate the impact of the prize and support the broader Texas research community.
    Contact TAMEST

    For questions, please contact TAMEST Program Director Stephanie Shaw at (512) 471-3823 or stephanie.shaw@austin.utexas.edu

    2026 Hill Prizes Recipients

    2026 Hill Prize in Artificial Intelligence: Kristen Grauman, Ph.D.

    2026 Hill Prize in Artificial Intelligence
    Kristen Grauman, Ph.D.

    Professor
    Department of Computer Science
    The University of Texas at Austin

    For pioneering research on video understanding models that help people acquire physical and procedural skills.

    Read the summary statement and abstract from their winning proposal.

    Co-PIs: Georgios Pavlakos, Ph.D., Assistant Professor, Department of Computer Science, The University of Texas at Austin; Amy Pavel, Ph.D., Assistant Professor, University of California, Berkeley; Hao-Yuan Hsiao, Ph.D., Associate Professor, Kinesiology & Health Education, The University of Texas at Austin; Travis Vlantes, Director, Applied Sports Science, The University of Texas at Austin

    2026 Hill Prize in Biological Sciences: Susan M. Rosenberg, Ph.D.

    2026 Hill Prize in Biological Sciences
    Susan M. Rosenberg, Ph.D.

    Ben F. Love Chair in Cancer Research and Professor of Molecular & Human Genetics
    Biochemistry & Molecular Pharmacology, and Molecular Virology & Microbiology
    Dan L Duncan Comprehensive Cancer Center
    Baylor College of Medicine

    For her groundbreaking strategy to combat antibiotic resistance by targeting the evolutionary process itself.

    Read the summary statement and abstract from their winning proposal.

    Co-PI: Christophe Herman, Ph.D., Professor, Baylor College of Medicine

    2026 Hill Prize in Engineering: Naomi J. Halas, Ph.D., D.Sc. (NAE, NAS), and Co-Recipients Peter J. A. Nordlander, Ph.D., and Hossein Robatjazi, Ph.D.

    2026 Hill Prize in Engineering
    Naomi J. Halas, Ph.D., D.Sc. (NAE, NAS)

    University Professor and Stanley C. Moore Professor of Electrical and Computer Engineering
    Rice University

    Co-Recipients Peter J. A. Nordlander, Ph.D., Rice University, and Hossein Robatjazi, Ph.D., Syzygy Plasmonics Inc. and Rice University

    To advance light-driven technologies for sustainable ammonia synthesis.

    Read the summary statement and abstract from their winning proposal.

    2026 Hill Prize in Medicine: Raghu Kalluri, M.D., Ph.D.

    2026 Hill Prize in Medicine
    Raghu Kalluri, M.D., Ph.D.

    Department of Cancer Biology
    The University of Texas MD Anderson Cancer Center

    For developing eye drops to treat age-related macular degeneration (AMD) and other posterior eye diseases.

    2026 Hill Prize in Physical Sciences: Karen L. Wooley, Ph.D. (NAS), and Co-Recipient Matthew Stone

    2026 Hill Prize in Physical Sciences
    Karen L. Wooley, Ph.D. (NAE, NAS)

    W.T. Doherty-Welch Chair and Distinguished Professor of Chemistry
    Texas A&M University

    Co-Recipient: Matthew Stone, Managing Director, Teysha Technologies

    For innovative research that transforms agricultural waste into safe, degradable plastics and chemicals.

    Read the summary statement and abstract from their winning proposal.

    Co-PIs and Team Members: Senthil K. Boopathi, Associate Research Scientist, Department of Chemistry, Texas A&M University; Ashlee A. Jahnke, Ph.D., Research Scientist, Department of Chemistry, Texas A&M University; Co-Founder, Sugar Plastics, Director of R&D, Teysha Technologies

    2026 Hill Prize in Public Health: Elizabeth C. Matsui, M.D.

    2026 Hill Prize in Public Health
    Elizabeth C. Matsui, M.D.

    Professor of Pediatrics and the Director of Environmental Health in the Center for Human Immunology, Baylor College of Medicine
    Professor of Population Health and Pediatrics, Dell Medical School
    Director, Center for Health and Environment: Education and Research, The University of Texas at Austin

    For identifying climate change-related environmental exposures – specifically extreme heat and air pollution – as key contributors to adverse maternal and birth outcomes and associated disparities.

    Read the summary statement and abstract from their winning proposal.

    Co-PIs and Team Members: Alison Cahill, M.D., Professor of Women’s Health, The University of Texas at Austin; Sarah Chambliss, Ph.D., Instructor, The University of Texas at Austin; Catherine Cubbin, Ph.D., Professor, School of Social Work, The University of Texas at Austin; Roger D. Peng, Ph.D., Professor of Statistics and Data Science, The University of Texas at Austin; Geeta Persad, Ph.D., Assistant Professor of Climate Science, The University of Texas at Austin

    2026 Hill Prize in Technology: Kurt W. Swogger and Co-Recipients Clive Bosnyak, Ph.D., and August Krupp

    2026 Hill Prize in Technology
    Kurt W. Swogger

    Chief Executive Officer and Co-Founder
    Molecular Rebar Design, LLC

    Co-Recipients Clive Bosnyak, Ph.D., Molecular Rebar Design, LLC and August Krupp, Molecular Rebar Design, LLC

    For addressing critical environmental and safety concerns related to tire performance and chemical toxicity.

    Read the summary statement and abstract from their winning proposal.

    Meet Our Committee

    A committee of TAMEST members (Texas-based members of the National Academies) evaluates applicants and recommends finalists in consultation with a panel of National Academies members from outside of Texas.
    David Daniel

    David E. Daniel, Ph.D. (NAE)

    Hill Prizes Committee Chair
    President Emeritus, The University of Texas at Dallas
    Past President, TAMEST

    Artificial Intelligence

    • Subcommittee Chair: Lydia E. Kavraki, Ph.D. (NAM, NAE, NAS), Rice University
    • Pallab K. Chatterjee, Ph.D. (NAE), 3Lines Venture Capital
    • Mark Papermaster (NAE), AMD
    • Karen E. Willcox, Ph.D. (NAE), The University of Texas at Austin

    Biological Sciences

    • Subcommittee Chair: Richard A. Dixon D. Phil, D.Sc. (NAS, FRS), University of North Texas
    • Guillermina “Gigi” Lozano, Ph.D. (NAM, NAS), The University of Texas MD Anderson Cancer Center
    • Margaret Phillips, Ph.D. (NAS), UT Southwestern Medical Center<.li>
    • Huda Y. Zoghbi, M.D. (NAM, NAS), Baylor College of Medicine

    Commercialization, Innovation and Technology

    • Subcommittee Chair: Lynda Chin, M.D. (NAM), Apricity Health
    • Amos A. Avidan, Ph.D. (NAE), Bechtel Corporation
    • Dale Klein, Ph.D. (NAE), The University of Texas at Austin
    • Mary Pat Moyer, Ph.D. (NAE), INCELL Corporation LLC

    Engineering

    • Subcommittee Chair: Joan Frances Brennecke, Ph.D. (NAE)*, The University of Texas at Austin
    • James J. Coleman, Ph.D. (NAE), The University of Texas at Arlington
    • Kaushik Rajashekara, Ph.D. (NAE), University of Houston
    • Jerome Schultz, Ph.D. (NAE), University of Houston

    Medicine

    • Subcommittee Chair: Martin M. Matzuk, M.D., Ph.D. (NAS)*, Baylor College of Medicine
    • Florence P. Haseltine, M.D., Ph.D. (NAM), The University of Texas at Arlington
    • Bettie Sue Masters, Ph.D., D.Sc. (NAM), The University of Texas at San Antonio
    • Catherine Y. Spong, M.D. (NAM), Committee Vice Chair, UT Southwestern Medical Center

    Physical Sciences

    • Subcommittee Chair: Peter G. Wolynes, Ph.D. (NAS), Rice University
    • Paul C.W. Chu, Ph.D. (NAS), University of Houston
    • Marcetta Y. Darensbourg, Ph.D. (NAS), Texas A&M University
    • William H. Press, Ph.D. (NAS), The University of Texas at Austin

    Public Health

    • Subcommittee Chair: William M. Sage, M.D., J.D. (NAM), Texas A&M Health and Texas A&M University
    • Ellen R. Gritz, Ph.D. (NAM), The University of Texas MD Anderson Cancer Center
    • Carlos Roberto Jaén, M.D., Ph.D. (NAM), The University of Texas at San Antonio
    • Charles B. Nemeroff, M.D., Ph.D. (NAM), The University of Texas at Austin Dell Medical School

    *Past Recipient of a Hill Prize

    Nobel and Breakthrough Prize Laureates Committee

    A committee of Texas Nobel and Breakthrough Prize Laureates reviews and endorses the finalists.
    James P. Allison, Ph.D. (NAM, NAS)
    Chair, Department of Immunology and Executive Director, Immunotherapy Platform
    Deputy Director, David H. Koch Center for Applied Research of Genitourinary Cancers
    The University of Texas MD Anderson Cancer Center
    Nobel Prize in Physiology or Medicine, 2018

    Bruce A. Beutler, M.D. (NAM, NAS)
    Regental Professor
    Director of the Center for Genetics of Host Defense
    UT Southwestern Medical Center
    Nobel Prize in Physiology or Medicine, 2011

    Zhijian “James” Chen, Ph.D. (NAM, NAS, FRS)
    Howard Hughes Medical Institute
    George L. MacGregor Distinguished Chair in Biomedical Science
    Professor, Department of Molecular Biology
    UT Southwestern Medical Center
    Breakthrough Prize in Life Sciences, 2019

    Johann Deisenhofer, Ph.D. (NAS)
    Regental Professor Virginia and Edward Linthicum Distinguished Chair in Biomolecular Science
    UT Southwestern Medical Center
    Nobel Prize in Chemistry, 1988

    Helen H. Hobbs, M.D. (NAM, NAS)
    Director, Eugene McDermott Center for Growth and Development; Professor of Internal Medicine and Molecular Genetics
    Howard Hughes Investigator
    UT Southwestern Medical Center
    Breakthrough Prize in Life Sciences, 2015

    Huda Y. Zoghbi, M.D. (NAM, NAS)
    Distinguished Service Professor, Department of Molecular and Human Genetics
    Director, Jan and Dan Duncan Neurological Research Institute
    Investigator, Howard Hughes Medical Institute
    Baylor College of Medicine
    Breakthrough Prize in Life Sciences, 2017

    Funders

    Lyda Hill Philanthropies

    About Lyda Hill Philanthropies

    Lyda Hill Philanthropies encompasses the charitable giving for founder Lyda Hill and includes her foundation and personal philanthropy. Her organization is committed to funding transformational advances in science and nature, empowering nonprofit organizations and improving the Texas and Colorado communities. Because Miss Hill has a fervent belief that “science is the answer” to many of life’s most challenging issues, she has chosen to donate the entirety of her estate to philanthropy and scientific research. For more details, visit lydahillphilanthropies.org.

    TAMEST Logo

    TAMEST News and Updates

    This field is for validation purposes and should be left unchanged.
    Name(Required)